{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T16:08:46Z","timestamp":1707754126661},"reference-count":59,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jacl.2017.08.006","type":"journal-article","created":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T14:19:53Z","timestamp":1503584393000},"page":"1383-1392","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Severe hypertriglyceridemia in Japan: Differences in causes and therapeutic responses"],"prefix":"10.1016","volume":"11","author":[{"given":"Toshio","family":"Murase","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsu","family":"Ebara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasumichi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2017.08.006_bib1","series-title":"The Metabolic and Molecular Basis of Inherited Disease","first-page":"2789","article-title":"Familial lipoprotein lipase deficiency, apoCII deficiency and hepatic lipase deficiency","author":"Brunzell","year":"2001"},{"key":"10.1016\/j.jacl.2017.08.006_bib2","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1161\/ATVBAHA.107.150680","article-title":"Resequencing genomic DNA of patients with severe hypertriglyceridemia (MIM 144650)","volume":"27","author":"Wang","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2017.08.006_bib3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jacl.2015.12.015","article-title":"Pathogenic classification of LPL gene variants reported to be associated with LPL deficiency","volume":"10","author":"Rodrigues","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2017.08.006_bib4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/01.ATV.0000153087.36428.dd","article-title":"Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia","volume":"25","author":"Oliva","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2017.08.006_bib5","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/ng.2007.24","article-title":"Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia","volume":"39","author":"P\u00e9terfy","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacl.2017.08.006_bib6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10545-011-9406-5","article-title":"Deletion of GPIHBP1 causing severe chylomicronemia","volume":"35","author":"Rios","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jacl.2017.08.006_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2796.2012.02516.x","article-title":"Mutations in LPL, APOC2, APOA5, GPIHBP1, and LMF1 in patients [with severe in patients] with severe hypertriglyceridaemia","volume":"272","author":"Surendan","year":"2012","journal-title":"J Intern Med"},{"key":"10.1016\/j.jacl.2017.08.006_bib8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/MOL.0b013e3283471972","article-title":"Genetic bases of hypertriglyceridemic phenotypes","volume":"22","author":"Johansen","year":"2011","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2017.08.006_bib9","first-page":"2258","article-title":"Triglyceride turnover: a comparison of simultaneous determinations using the radioglyceride and the lipolytic rate procedures","volume":"34","author":"Steiner","year":"1975","journal-title":"Fed Proc"},{"key":"10.1016\/j.jacl.2017.08.006_bib10","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/0026-0495(80)90112-2","article-title":"Decline of postheparin plasma lipoprotein lipase in acromegalic patients","volume":"29","author":"Murase","year":"1980","journal-title":"Metabolism"},{"key":"10.1016\/j.jacl.2017.08.006_bib11","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1172\/JCI115507","article-title":"Heterogeneous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency","volume":"88","author":"Gotoda","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2017.08.006_bib12","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1194\/jlr.D500018-JLR200","article-title":"A sandwich-enzyme linked immunosorbent assay for human plasma apolipoprotein A-V concentration","volume":"46","author":"Ishihara","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2017.08.006_bib13","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.metabol.2007.04.015","article-title":"Impact of markedly elevated serum lipoprotein(a) levels (\u2265100mg\/dL) on the risk of coronary heart disease","volume":"56","author":"Murase","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.jacl.2017.08.006_bib14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jacl.2015.05.004","article-title":"Clinical characteristics of Japanese patients with severe hypertriglyceridemia","volume":"9","author":"Tada","year":"2015","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2017.08.006_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12944-017-0511-9","article-title":"Severe hypertriglyceridemia in Norway: prevalence, clinical and genetic characteristics","volume":"16","author":"Retterst\u00f8l","year":"2017","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jacl.2017.08.006_bib16","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.amjcard.2010.11.008","article-title":"Prevalence of severe (500 to 2000 mg\/dl) hypertriglyceridemia in United States adults","volume":"107","author":"Christian","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2017.08.006_bib17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0925-4439(92)90015-F","article-title":"A newly identified null allelic mutation in the human lipoprotein lipase (LPL) gene of a compound heterozygote with familial LPL deficiency","volume":"1138","author":"Gotoda","year":"1992","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jacl.2017.08.006_bib18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0021-9150(99)00008-8","article-title":"Detection of a new compound heterozygote (del G916\/G1401A) for lipoprotein lipase deficiency and a comparative haplotype analysis of the mutant lipoprotein lipase gene from Japanese patients","volume":"144","author":"Okubo","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2017.08.006_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5551\/jat1994.7.45","article-title":"Japanese patient with lipoprotein lipase deficiency homozygous for the Gly188Glu mutation prevalent worldwide","volume":"7","author":"Yoshida","year":"2000","journal-title":"J Atheroscler Thromb"},{"issue":"2","key":"10.1016\/j.jacl.2017.08.006_bib20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0021-9150(01)00510-X","article-title":"No evidence of accelerated atherosclerosis in a 66-yr-old chylomicronemia patient homozygous for the nonsense mutation (Tyr61\u2192Stop) in the lipoprotein lipase gene","volume":"159","author":"Ebara","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2017.08.006_bib21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ymgme.2007.06.018","article-title":"A novel complex deletion-insertion mutation mediated by Alu repetitive elements leads to lipoprotein lipase deficiency","volume":"92","author":"Okubo","year":"2007","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jacl.2017.08.006_bib22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cca.2007.08.011","article-title":"60-y-old chylomicronemia patient homozygous for missense mutation (G188E) in the lipoprotein lipase gene showed no accelerated atherosclerosis","volume":"386","author":"Ebara","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jacl.2017.08.006_bib23","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1073\/pnas.86.3.948","article-title":"A major insertion accounts for a significant proportion of mutations underlying human lipoprotein lipase deficiency","volume":"86","author":"Langlois","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacl.2017.08.006_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0003-3995(01)01037-1","article-title":"Lipoprotein lipase (LPL) deficiency: a new patient homozygote for the preponderant mutation gly88-to-glu in the human LPL gene and review of reported mutations: 75% are clustered in exons 5 and 6","volume":"44","author":"Gilbert","year":"2001","journal-title":"Ann Genet"},{"key":"10.1016\/j.jacl.2017.08.006_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5551\/jat.10702","article-title":"Diagnosis and management of Type I and Type V hyperlipoproteinemia","volume":"19","author":"Gotoda","year":"2012","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jacl.2017.08.006_bib26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0021-9150(96)06061-3","article-title":"A G+1 to C mutation in a donor splice site of intron 2 in the apolipoprotein (apo) C-II gene in a patient with apo C-II deficiency: a possible interaction between apo C-II deficiency and apo E4 in a severely hypertriglyceridemic patient","volume":"130","author":"Okubo","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2017.08.006_bib27","doi-asserted-by":"crossref","first-page":"481","DOI":"10.5551\/jat.16592","article-title":"Apolipoprotein C-II deficiency with no rare variant in the APOC2 gene","volume":"20","author":"Takase","year":"2013","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jacl.2017.08.006_bib28","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJM197806082982301","article-title":"Hypertriglyceridemia associated with deficiency of apolipoprotein C-II","volume":"298","author":"Breckenridge","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2017.08.006_bib29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.atherosclerosis.2009.03.046","article-title":"A novel APOA5 splicing mutation IVS2+1g> in a Japanese patient","volume":"207","author":"Okubo","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2017.08.006_bib30","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.jacl.2016.03.009","article-title":"Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene","volume":"10","author":"Rabacchi","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2017.08.006_bib31","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1210\/jc.2009-0594","article-title":"Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia","volume":"94","author":"Cefalu","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2017.08.006_bib32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0021-9150(81)90015-0","article-title":"Accumulation of intermediate density lipoprotein in plasma after intravenous administration of hepatic triglyceride lipase antibody in rats","volume":"39","author":"Murase","year":"1981","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2017.08.006_bib33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0021-9150(82)90136-8","article-title":"Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase","volume":"45","author":"Breckenridge","year":"1982","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2017.08.006_bib34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MPA.0b013e3181771659","article-title":"Pancreatitis caused by hypertriglyceridemia in a patient compound heterozygous for Leu334Phen and -514C\u2192T in the hepatic lipase gene","volume":"38","author":"Ebara","year":"2009","journal-title":"Pancreas"},{"key":"10.1016\/j.jacl.2017.08.006_bib35","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1056\/NEJM198905113201906","article-title":"Autoimmune hyperchylomicronemia","volume":"320","author":"Kihara","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2017.08.006_bib36","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa1611930","article-title":"Autoantibodies against GPIHBP1 as a cause of hypertriglyceridemia","volume":"376","author":"Beigneux","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2017.08.006_bib37","series-title":"The Metabolic and Molecular Bases of Inherited Disease","article-title":"Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism","author":"Mahley","year":"2001"},{"key":"10.1016\/j.jacl.2017.08.006_bib38","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jacl.2012.01.007","article-title":"Non-HDL-cholesterol\/apolipoprotein B ratio: a useful distinguishing feature in the screening for type III hypertriglyceridemia","volume":"6","author":"Murase","year":"2012","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2017.08.006_bib39","first-page":"187","article-title":"A novel apolipoprotein E2 variant, E2Toranomon (Q187E), identified in a type III hyperlipoproteinemia patient with coronary atherosclerosis","volume":"140","author":"Okubo","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2017.08.006_bib40","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cca.2012.08.028","article-title":"Hepatic lipase activity is decreased in Japanese patients with type III hyperlipoproteinemia","volume":"414","author":"Murase","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jacl.2017.08.006_bib41","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJM196702232760802","article-title":"Diabetic lipemia \u2013 a form of acquired fat-induced lipemia","volume":"276","author":"Bagdade","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2017.08.006_bib42","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/0026-0495(75)90129-8","article-title":"Serum lipids in acromegaly","volume":"24","author":"Nikkil\u00e4","year":"1975","journal-title":"Metabolism"},{"key":"10.1016\/j.jacl.2017.08.006_bib43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/2251-6581-12-25","article-title":"Glycogen storage disease type 1a \u2013 a secondary cause for hyperlipidemia","volume":"12","author":"Carvalho","year":"2013","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.jacl.2017.08.006_bib44","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0049-0172(96)80005-9","article-title":"Successful treatment of severe cytophagic histiocytic panniculitis with cyclosporine","volume":"25","author":"Ostrov","year":"1996","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jacl.2017.08.006_bib45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jacl.2007.11.001","article-title":"Hypertriglyceridemia-induced created by oral estrogen and in\u00a0vitro fertilization ovulation induction","volume":"2","author":"Lee","year":"2008","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2017.08.006_bib46","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1016\/j.ejca.2014.06.023","article-title":"Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukemia","volume":"50","author":"Bhojwani","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jacl.2017.08.006_bib47","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0005-2760(76)90194-6","article-title":"Regulation of lipoprotein lipase. Induction by insulin","volume":"424","author":"Garfinkel","year":"1976","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jacl.2017.08.006_bib48","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jacl.2012.08.005","article-title":"Glycogen storage disease type Ia, glycogen, lactic acid, triglyceride, and uric acid metabolism","volume":"6","author":"Sever","year":"2012","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2017.08.006_bib49","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2169\/internalmedicine1962.28.366","article-title":"Dyslipoproteinemia and an inhibitor of lipolytic enzymes in Weber-Christian disease","volume":"28","author":"Shirai","year":"1989","journal-title":"Jpn J Med"},{"key":"10.1016\/j.jacl.2017.08.006_bib50","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/sj.leu.2400703","article-title":"Transient hyperlipidemia during treatment of ALL with L-asparaginase is related to decreased lipoprotein lipase activity","volume":"11","author":"Hoogerbrugge","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.jacl.2017.08.006_bib51","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0026-0495(83)90184-1","article-title":"Severe hypertriglyceridemia: role of familial and acquired disorders","volume":"32","author":"Chait","year":"1983","journal-title":"Metabolism"},{"key":"10.1016\/j.jacl.2017.08.006_bib52","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/alcalc\/agq088","article-title":"Severe hypertriglyceridemia influenced by alcohol (SHIBA)","volume":"46","author":"Bessembinders","year":"2011","journal-title":"Alcohol Alcohol"},{"issue":"Suppl 3","key":"10.1016\/j.jacl.2017.08.006_bib53","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.2337\/diab.45.3.S123","article-title":"Hypertriglyceridemia and low HDL cholesterol in Japanese patients with NIDDM","volume":"45","author":"Okubo","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.jacl.2017.08.006_bib54","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1152\/ajpendo.00011.2008","article-title":"Alcohol and lipid metabolism","volume":"295","author":"Sozio","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jacl.2017.08.006_bib55","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1172\/JCI106290","article-title":"Effects of chronic ethanol-feeding on serum lipoprotein metabolism in the rat","volume":"49","author":"Baraona","year":"1970","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2017.08.006_bib56","first-page":"384","article-title":"Alcoholic hyperlipidemia: induction by alcohol but not by carbohydrate","volume":"77","author":"Kudzma","year":"1971","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jacl.2017.08.006_bib57","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S2213-8587(13)70191-8","article-title":"The polygenic nature of hypertriglyceridemia: implications for definition, diagnosis, and management","volume":"2","author":"Hegel","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacl.2017.08.006_bib58","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/ajg.2009.27","article-title":"Hypertriglyceridemic pancreatitis: presentation and management","volume":"104","author":"Tsuang","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jacl.2017.08.006_bib59","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/MPG.0000000000000363","article-title":"Whole-exome sequencing reveals GPIHBP1 mutations in a case of infantile colitis with severe hypertriglyceridemia","volume":"59","author":"Gonzaga-Jauregui","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287417304117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287417304117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T10:20:07Z","timestamp":1535451607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287417304117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1933287417304117"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2017.08.006","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe hypertriglyceridemia in Japan: Differences in causes and therapeutic responses","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2017.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 National Lipid Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}